FDA Clears New Software for Draeger Evita V800 Ventilator
The update introduces features designed to assist clinicians in managing patients with pulmonary diseases like acute respiratory distress syndrome.
The update introduces features designed to assist clinicians in managing patients with pulmonary diseases like acute respiratory distress syndrome.
A manufacturing error may lead to undetected oxygen leaks, posing risks of reduced oxygen delivery and potential fire hazards.
The system uses artificial intelligence to provide real-time guidance for brain biopsies, shunt placements, and other neurosurgical procedures.
The platform combines ultrasound and optical imaging to provide detailed views of coronary anatomy in a single workflow.
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.